Evidence map›Paper›PMID 22761415›Full record

ArticleThe Journal of biological chemistry2012

TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.

Soo-Hyun Yoon, Yong Deok Lee, Jeongim Ha, Youngkyun Lee, Hong-Hee Kim

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Platelet biology of the rapidly failing lung.British journal of haematology · 2020
    Review
  7. Article
  8. Article
  9. TREM2 in Neurodegenerative Diseases.Molecular neurodegeneration · 2017
    Review
  10. TREM2-Ligand Interactions in Health and Disease.Journal of molecular biology · 2017
    Review
  11. Article
  12. A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.Clinical reviews in allergy & immunology · 2016
    Review
  13. Review
  14. Review
  15. Emerging Roles for Platelets in Inflammation and Disease.Journal of infectious disease and therapy · 2014
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Soo-Hyun YoonDepartment of Cell and Developmental Biology, BK21 and DRI, Seoul National University, Seoul, Korea.
Yong Deok Lee
Jeongim Ha
Youngkyun Lee
Hong-Hee Kim
Seoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triggering receptor expressed on myeloid cells (TREM)-like transcript-1 (TLT-1) is an immunoreceptor tyrosine-based inhibitory motif (ITIM)-baring TREM family protein. In this study, we identified an alternative transcript form of TLT-1, namely TLT-1s, which has very short extracellular immunoglobulin domain consisting of only 202 amino acids. TLT-1s was mainly expressed in macrophages and osteoclast precursor cells. Upon receptor activator of nuclear factor-κB ligand stimulation, TLT-1s mRNA and protein levels were gradually decreased in BMMs. We also showed the TLT-1s is localized to the cytoplasmic membrane in osteoclast precursor cells. TLT-1s silencing strongly enhanced the formation and resorption activity of osteoclast. In addition, forced expression of TLT-1s showed reduced formation of osteoclast. Because ITIM-baring proteins inhibit immunoreceptor tyrosine-based activation motif (ITAM)-mediated receptor signaling, we tested whether TLT-1s physically interacted with TREM-2, the ITAM-associated co-stimulatory receptor essential for osteoclast differentiation. We showed that TLT-1s is associated with TREM-2 in osteoclast precursor cells. TLT-1s is also associated with tyrosine Src homology 2 domain-containing phosphatase-1 and SH2 domain-containing inositol phosphatase-1 and recruited them to the TREM2-ITAM signaling complex. In addition, knockdown of TLT-1s markedly elevated the intracellular calcium concentration and oscillation in osteoclast precursor cells. In addition, calcium-mediated induction of nuclear factor of activated T cells was also increased by TLT-1s silencing. Furthermore, TREM-2-mediated Akt activation and proliferation of osteoclast precursor cells were also enhanced in TLT-1s silenced cells. In this paper, we found the noble ITIM-baring inhibitory membrane protein; TLT-1s, which regulates ITAM-mediated signaling on osteoclastogenesis.

Indexed as

Alternative SplicingAmino Acid MotifsAnimalsCell MembraneCells, CulturedEnzyme ActivationGene SilencingMembrane GlycoproteinsMiceNF-kappa BOsteoclastsPhosphoprotein PhosphatasesProto-Oncogene Proteins c-aktReceptors, ImmunologicRNA, MessengerSignal TransductionMembrane GlycoproteinsNF-kappa BPhosphoprotein PhosphatasesProto-Oncogene Proteins c-aktReceptors, ImmunologicRNA, MessengerTrem2 protein, mouseTreml1 protein, mouse

Identifiers

PMID22761415
PMCPMC3436187
OpenAlexW2053740009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.